"Designing Growth Strategies is in our DNA"

Plasma Fractionation Market Size, Share & Industry Analysis, By Product (Albumin, Immunoglobulin {IVIG and SCIG}, Coagulation Factors {Factor IX, Factor VIII, and von Willebrand Factor}, and Protease Inhibitors {Alpha-1 Antitrypsin and C1 Esterase Inhibitor}), By Application (Immunology, Neurology, Hematology, Critical Care, and Pulmonology), By End User (Hospitals & Clinics, Specialty Clinics & Infusion Centers, and Homecare Settings), and Regional Forecast, 2026-2034

Last Updated: July 27, 2026 | Format: PDF | Report ID: FBI101614

 

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges
    5. Market Trends 
  4. Key Insights
    1. Plasma Fractionation Capacity, By Key Players
    2. Number of Plasma Collection Centers, By Key Countries 
    3. Cost Breakdown of Plasma Fractionation, By Key Countries
    4. Regional Distribution of Plasma Fractionation Throughput
    5. Prevalence of Chronic Diseases (Key Indications), By Key Countries
    6. Pricing Analysis, Plasma Fractionated Products, By Key Countries
    7. Regulatory Scenario, By Key Countries
    8. Overview : Plasma Collection Technologies
    9. Pipeline Analysis, By Key Companies
    10. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    11. Porter’s Five Forces Analysis
    12. PESTEL Analysis
    13. Value Chain Analysis
    14. Price Trend Analysis
  5. Global Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others 
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Product
      2. Canada
        1. By Product
  7. Europe Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
        1. By Product
      2.  Germany
        1.  By Product
      3.  France
        1.  By Product
      4.  Spain
        1.  By Product
      5.  Italy
        1. By Product
      6.  Scandinavia
        1.  By Product
      7.  Rest of Europe
        1.  By Product
  8. Asia Pacific Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Japan
        1.  By Product
      2. China
        1.  By Product
      3. India
        1.  By Product
      4. Australia
        1. By Product
      5. Southeast Asia
        1. By Product
      6. Rest of Asia Pacific
        1.  By Product 
  9. Latin America Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
        1. By Product
      2. Mexico
        1. By Product 
      3. Rest of Latin America
        1. By Product
  10. Middle East & Africa Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
        1. By Product
      2. South Africa
        1. By Product
      3. Rest of Middle East & Africa
        1. By Product 
  11. Competitive Analysis 
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. CSL
      2. Grifols, S.A.
      3. Takeda Pharmaceutical Company Limited
      4. Octapharma AG
      5. Kedrion S.p.A. 
      6. LFB Group
      7. ADMA Biologics, Inc.
      8. GC Biopharma corporate
      9. Beijing Tiantan Biological Products Co., Ltd.
      10. Shanghai RAAS Blood Products Co., Ltd. 
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges
    5. Market Trends 
  4. Key Insights
    1. Plasma Fractionation Capacity, By Key Players
    2. Number of Plasma Collection Centers, By Key Countries 
    3. Cost Breakdown of Plasma Fractionation, By Key Countries
    4. Regional Distribution of Plasma Fractionation Throughput
    5. Prevalence of Chronic Diseases (Key Indications), By Key Countries
    6. Pricing Analysis, Plasma Fractionated Products, By Key Countries
    7. Regulatory Scenario, By Key Countries
    8. Overview : Plasma Collection Technologies
    9. Pipeline Analysis, By Key Companies
    10. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    11. Porter’s Five Forces Analysis
    12. PESTEL Analysis
    13. Value Chain Analysis
    14. Price Trend Analysis
  5. Global Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others 
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Product
      2. Canada
        1. By Product
  7. Europe Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
        1. By Product
      2.  Germany
        1.  By Product
      3.  France
        1.  By Product
      4.  Spain
        1.  By Product
      5.  Italy
        1. By Product
      6.  Scandinavia
        1.  By Product
      7.  Rest of Europe
        1.  By Product
  8. Asia Pacific Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Japan
        1.  By Product
      2. China
        1.  By Product
      3. India
        1.  By Product
      4. Australia
        1. By Product
      5. Southeast Asia
        1. By Product
      6. Rest of Asia Pacific
        1.  By Product 
  9. Latin America Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
        1. By Product
      2. Mexico
        1. By Product 
      3. Rest of Latin America
        1. By Product
  10. Middle East & Africa Plasma Fractionation Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Product
      1. Albumin
      2. Immunoglobulin
        1. Intravenous Immunoglobulin
        2. Subcutaneous Immunoglobulin
      3. Coagulation Factors
        1. Factor IX
        2. Factor VIII
        3. Prothrombin Complex Concentrates
        4. Fibrinogen Concentrates
        5. von Willebrand Factor
        6. Antithrombin
        7. Others
      4. Protease Inhibitors
        1. Alpha-1 Antitrypsin
        2. C1 Esterase Inhibitor
        3. Others
      5. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Immunology 
      2. Neurology
      3. Hematology
      4. Critical Care
      5. Pulmonology
      6. Infectious Disease
      7. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Specialty Clinics & Infusion Centers
      3. Homecare Settings
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
        1. By Product
      2. South Africa
        1. By Product
      3. Rest of Middle East & Africa
        1. By Product 
  11. Competitive Analysis 
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. CSL
      2. Grifols, S.A.
      3. Takeda Pharmaceutical Company Limited
      4. Octapharma AG
      5. Kedrion S.p.A. 
      6. LFB Group
      7. ADMA Biologics, Inc.
      8. GC Biopharma corporate
      9. Beijing Tiantan Biological Products Co., Ltd.
      10. Shanghai RAAS Blood Products Co., Ltd. 
Read Less

Figure 1: Global Plasma Fractionation Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Plasma Fractionation Market Value Share (%), by Product, 2025 & 2034

Figure 3: Global Plasma Fractionation Market Value Share (%), by Application, 2025 & 2034

Figure 4: Global Plasma Fractionation Market Value Share (%), by End User, 2025 & 2034

Figure 5: Global Plasma Fractionation Market Value Share (%), by Region, 2025 & 2034

Figure 6:  North America Plasma Fractionation Market Value (USD billion), by Product 2025 & 2034

Figure 7:  North America Plasma Fractionation Market Value Share (%), by Product 2025

Figure 8:  North America Plasma Fractionation Market Value (USD billion), by Application, 2025 & 2034

Figure 9:  North America Plasma Fractionation Market Value Share (%), by Application, 2025

Figure 10: North America Plasma Fractionation Market Value (USD billion), by End User, 2025 & 2034

Figure 11: North America Plasma Fractionation Market Value Share (%), by End User, 2025

Figure 12: North America Plasma Fractionation Market Value (USD billion), by Country, 2025 & 2034

Figure 13: North America Plasma Fractionation Market Value Share (%), by Country, 2025

Figure 14: Europe Plasma Fractionation Market Value (USD billion), by Product 2025 & 2034

Figure 15: Europe Plasma Fractionation Market Value Share (%), by Product 2025

Figure 16: Europe Plasma Fractionation Market Value (USD billion), by Application, 2025 & 2034

Figure 17: Europe Plasma Fractionation Market Value Share (%), by Application, 2025

Figure 18: Europe Plasma Fractionation Market Value (USD billion), by End User, 2025 & 2034

Figure 19: Europe Plasma Fractionation Market Value Share (%), by End User, 2025

Figure 20: Europe Plasma Fractionation Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 21: Europe Plasma Fractionation Market Value Share (%), by Country/ Sub-region, 2025

Figure 22:  Asia Pacific Plasma Fractionation Market Value (USD billion), by Product 2025 & 2034

Figure 23:  Asia Pacific Plasma Fractionation Market Value Share (%), by Product 2025

Figure 24:  Asia Pacific Plasma Fractionation Market Value (USD billion), by Application, 2025 & 2034

Figure 25:  Asia Pacific Plasma Fractionation Market Value Share (%), by Application, 2025

Figure 26:  Asia Pacific Plasma Fractionation Market Value (USD billion), by End User, 2025 & 2034

Figure 27:  Asia Pacific Plasma Fractionation Market Value Share (%), by End User, 2025

Figure 28:  Asia Pacific Plasma Fractionation Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 29:  Asia Pacific Plasma Fractionation Market Value Share (%), by Country/ Sub-region, 2025

Figure 30: Latin America Plasma Fractionation Market Value (USD billion), by Product 2025 & 2034

Figure 31: Latin America Plasma Fractionation Market Value Share (%), by Product 2025

Figure 32: Latin America Plasma Fractionation Market Value (USD billion), by Application, 2025 & 2034

Figure 33: Latin America Plasma Fractionation Market Value Share (%), by Application, 2025

Figure 34: Latin America Plasma Fractionation Market Value (USD billion), by End User, 2025 & 2034

Figure 35: Latin America Plasma Fractionation Market Value Share (%), by End User, 2025

Figure 36: Latin America Plasma Fractionation Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 37: Latin America Plasma Fractionation Market Value Share (%), by Country/ Sub-region, 2025

Figure 38: Middle East & Africa Plasma Fractionation Market Value (USD billion), by Product 2025 & 2034

Figure 39: Middle East & Africa Plasma Fractionation Market Value Share (%), by Product 2025

Figure 40: Middle East & Africa Plasma Fractionation Market Value (USD billion), by Application, 2025 & 2034

Figure 41: Middle East & Africa Plasma Fractionation Market Value Share (%), by Application, 2025

Figure 42: Middle East & Africa Plasma Fractionation Market Value (USD billion), by End User, 2025 & 2034

Figure 43: Middle East & Africa Plasma Fractionation Market Value Share (%), by End User, 2025

Figure 44: Middle East & Africa Plasma Fractionation Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 45: Middle East & Africa Plasma Fractionation Market Value Share (%), by Country/ Sub-region, 2025

Figure 46: Global Plasma Fractionation Market Share (%), by Company, 2025

Table 1:  Global Plasma Fractionation Market Revenue (USD billion) Forecast, by Product, 2021–2034

Table 2:  Global Plasma Fractionation Market Revenue (USD billion) Forecast, by Immunoglobulins, 2021–2034

Table 3:  Global Plasma Fractionation Market Revenue (USD billion) Forecast, by Coagulation Factors, 2021–2034

Table 4:  Global Plasma Fractionation Market Revenue (USD billion) Forecast, by Protease Inhibitors, 2021–2034

Table 5:  Global Plasma Fractionation Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 6:  Global Plasma Fractionation Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 7:  Global Plasma Fractionation Market Revenue (USD billion) Forecast, by Region, 2021–2034

Table 8:  North America Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 9:  North America Plasma Fractionation Market Revenue (USD billion) Forecast, by Immunoglobulins, 2021–2034

Table 10:  North America Plasma Fractionation Market Revenue (USD billion) Forecast, by Coagulation Factors, 2021–2034

Table 11:  North America Plasma Fractionation Market Revenue (USD billion) Forecast, by Protease Inhibitors, 2021–2034

Table 12:  North America Plasma Fractionation Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 13:  North America Plasma Fractionation Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 14:  North America Plasma Fractionation Market Revenue (USD billion) Forecast, by Country, 2021–2034

Table 15:  U.S. Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 16: Canada Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 17: Europe Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 18: Europe Plasma Fractionation Market Revenue (USD billion) Forecast, by Immunoglobulins, 2021–2034

Table 19: Europe Plasma Fractionation Market Revenue (USD billion) Forecast, by Coagulation Factors, 2021–2034

Table 20: Europe Plasma Fractionation Market Revenue (USD billion) Forecast, by Protease Inhibitors, 2021–2034

Table 21: Europe Plasma Fractionation Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 22: Europe Plasma Fractionation Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 23: Europe Plasma Fractionation Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021–2034

Table 24:  U.K. Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 25: Germany Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 26: France Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 27:  Spain Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 28:  Italy Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 29: Scandinavia Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 30:  Rest of Europe Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 31:  Asia Pacific Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 32:  Asia Pacific Plasma Fractionation Market Revenue (USD billion) Forecast, by Immunoglobulins, 2021–2034

Table 33:  Asia Pacific Plasma Fractionation Market Revenue (USD billion) Forecast, by Coagulation Factors, 2021–2034

Table 34:  Asia Pacific Plasma Fractionation Market Revenue (USD billion) Forecast, by Protease Inhibitors, 2021–2034

Table 35:  Asia Pacific Plasma Fractionation Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 36:  Asia Pacific Plasma Fractionation Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 37:  Asia Pacific Plasma Fractionation Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021–2034

Table 38:  Japan Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 39:  China Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 40:  India Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 41: Australia Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 42: Southeast Asia Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 43:  Rest of Asia Pacific Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 44:  Latin America Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 45:  Latin America Plasma Fractionation Market Revenue (USD billion) Forecast, by Immunoglobulins, 2021–2034

Table 46:  Latin America Plasma Fractionation Market Revenue (USD billion) Forecast, by Coagulation Factors, 2021–2034

Table 47:  Latin America Plasma Fractionation Market Revenue (USD billion) Forecast, by Protease Inhibitors, 2021–2034

Table 48:  Latin America Plasma Fractionation Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 49:  Latin America Plasma Fractionation Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 50:  Latin America Plasma Fractionation Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021–2034

Table 51: Brazil America Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 52: Mexico America Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 53:  Rest of Latin America Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 54: Middle East & Africa Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 55: Middle East & Africa Plasma Fractionation Market Revenue (USD billion) Forecast, by Immunoglobulins, 2021–2034

Table 56: Middle East & Africa Plasma Fractionation Market Revenue (USD billion) Forecast, by Coagulation Factors, 2021–2034

Table 57: Middle East & Africa Plasma Fractionation Market Revenue (USD billion) Forecast, by Protease Inhibitors, 2021–2034

Table 58: Middle East & Africa Plasma Fractionation Market Revenue (USD billion) Forecast, by Application, 2021–2034

Table 59: Middle East & Africa Plasma Fractionation Market Revenue (USD billion) Forecast, by End User, 2021–2034

Table 60: Middle East & Africa Plasma Fractionation Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021–2034

Table 61:  GCC Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 62:  South Africa Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Table 63:  Rest of Middle East & Africa Plasma Fractionation Market Revenue (USD billion) Forecast, by Product 2021–2034

Plasma Fractionation Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 180
Download Free Sample

    man icon
    Mail icon
    Captcha refresh

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Customize Now
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports